368 related articles for article (PubMed ID: 32182145)
1. The potential role of using vaccine patches to induce immunity: platform and pathways to innovation and commercialization.
Badizadegan K; Goodson JL; Rota PA; Thompson KM
Expert Rev Vaccines; 2020 Feb; 19(2):175-194. PubMed ID: 32182145
[No Abstract] [Full Text] [Related]
2. Microneedle Patches as Drug and Vaccine Delivery Platform.
Li J; Zeng M; Shan H; Tong C
Curr Med Chem; 2017; 24(22):2413-2422. PubMed ID: 28552053
[TBL] [Abstract][Full Text] [Related]
3. Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin.
Prausnitz MR
Annu Rev Chem Biomol Eng; 2017 Jun; 8():177-200. PubMed ID: 28375775
[TBL] [Abstract][Full Text] [Related]
4. Dissolving Microneedle Patches for Dermal Vaccination.
Leone M; Mönkäre J; Bouwstra JA; Kersten G
Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
[TBL] [Abstract][Full Text] [Related]
5. Potential use of microarray patches for vaccine delivery in low- and middle- income countries.
Peyraud N; Zehrung D; Jarrahian C; Frivold C; Orubu T; Giersing B
Vaccine; 2019 Jul; 37(32):4427-4434. PubMed ID: 31262587
[TBL] [Abstract][Full Text] [Related]
6. Rabies vaccination in dogs using a dissolving microneedle patch.
Arya JM; Dewitt K; Scott-Garrard M; Chiang YW; Prausnitz MR
J Control Release; 2016 Oct; 239():19-26. PubMed ID: 27524283
[TBL] [Abstract][Full Text] [Related]
7. Microneedle Systems for Vaccine Delivery: the story so far.
Hossain MK; Ahmed T; Bhusal P; Subedi RK; Salahshoori I; Soltani M; Hassanzadeganroudsari M
Expert Rev Vaccines; 2020 Dec; 19(12):1153-1166. PubMed ID: 33427523
[TBL] [Abstract][Full Text] [Related]
8. Microneedle patches for vaccination in developing countries.
Arya J; Prausnitz MR
J Control Release; 2016 Oct; 240():135-141. PubMed ID: 26603347
[TBL] [Abstract][Full Text] [Related]
9. Assessing the Potential Cost-Effectiveness of Microneedle Patches in Childhood Measles Vaccination Programs: The Case for Further Research and Development.
Adhikari BB; Goodson JL; Chu SY; Rota PA; Meltzer MI
Drugs R D; 2016 Dec; 16(4):327-338. PubMed ID: 27696306
[TBL] [Abstract][Full Text] [Related]
10. Development of novel double-decker microneedle patches for transcutaneous vaccine delivery.
Ono A; Azukizawa H; Ito S; Nakamura Y; Asada H; Quan YS; Kamiyama F; Katayama I; Hirobe S; Okada N
Int J Pharm; 2017 Oct; 532(1):374-383. PubMed ID: 28855138
[TBL] [Abstract][Full Text] [Related]
11. Transdermal immunization: biological framework and translational perspectives.
Mishra DK; Dhote V; Mishra PK
Expert Opin Drug Deliv; 2013 Feb; 10(2):183-200. PubMed ID: 23256860
[TBL] [Abstract][Full Text] [Related]
12. Transcutaneous immunization with Intercell's vaccine delivery system.
Seid RC; Look JL; Ruiz C; Frolov V; Flyer D; Schafer J; Ellingsworth L
Vaccine; 2012 Jun; 30(29):4349-54. PubMed ID: 22682290
[TBL] [Abstract][Full Text] [Related]
13. Accelerating the development of vaccine microarray patches for epidemic response and equitable immunization coverage requires investment in microarray patch manufacturing facilities.
Scarnà T; Menozzi-Arnaud M; Friede M; DeMarco K; Plopper G; Hamer M; Chakrabarti A; Gilbert PA; Jarrahian C; Mistilis J; Hesselink R; Gandrup-Marino K; Amorij JP; Giersing B
Expert Opin Drug Deliv; 2023 Mar; 20(3):315-322. PubMed ID: 36649573
[TBL] [Abstract][Full Text] [Related]
14. Emerging skin-targeted drug delivery strategies to engineer immunity: A focus on infectious diseases.
Korkmaz E; Balmert SC; Carey CD; Erdos G; Falo LD
Expert Opin Drug Deliv; 2021 Feb; 18(2):151-167. PubMed ID: 32924651
[TBL] [Abstract][Full Text] [Related]
15. Transcutaneous vaccines--current and emerging strategies.
Hirobe S; Okada N; Nakagawa S
Expert Opin Drug Deliv; 2013 Apr; 10(4):485-98. PubMed ID: 23316778
[TBL] [Abstract][Full Text] [Related]
16. Microneedles for vaccine delivery: challenges and future perspectives.
Shin CI; Jeong SD; Rejinold NS; Kim YC
Ther Deliv; 2017 Jun; 8(6):447-460. PubMed ID: 28530151
[TBL] [Abstract][Full Text] [Related]
17. The potential effects of introducing microneedle patch vaccines into routine vaccine supply chains.
Wedlock PT; Mitgang EA; Elsheikh F; Leonard J; Bakal J; Welling J; Crawford J; Assy E; Magadzire BP; Bechtel R; DePasse JV; Siegmund SS; Brown ST; Lee BY
Vaccine; 2019 Jan; 37(4):645-651. PubMed ID: 30578088
[TBL] [Abstract][Full Text] [Related]
18. Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization.
Chen X; Fernando GJ; Crichton ML; Flaim C; Yukiko SR; Fairmaid EJ; Corbett HJ; Primiero CA; Ansaldo AB; Frazer IH; Brown LE; Kendall MA
J Control Release; 2011 Jun; 152(3):349-55. PubMed ID: 21371510
[TBL] [Abstract][Full Text] [Related]
19. Microarray patches: scratching the surface of vaccine delivery.
Choo JJY; McMillan CLD; Young PR; Muller DA
Expert Rev Vaccines; 2023; 22(1):937-955. PubMed ID: 37846657
[TBL] [Abstract][Full Text] [Related]
20. Microneedle patch delivery of influenza vaccine during pregnancy enhances maternal immune responses promoting survival and long-lasting passive immunity to offspring.
Esser ES; Pulit-Penaloza JA; Kalluri H; McAllister D; Vassilieva EV; Littauer EQ; Lelutiu N; Prausnitz MR; Compans RW; Skountzou I
Sci Rep; 2017 Jul; 7(1):5705. PubMed ID: 28720851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
